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Background: The initial COVID-19 pandemic shutdown led to the canceling of elective surgeries throughout most
of the USA and Canada.
Objective: This survey was carried out on behalf of the Parkinson Study Group (PSG) to understand the impact of
the shutdown on deep brain stimulation (DBS) practices in North America.
Methods: A survey was distributed through RedCap® to the members of the PSG Functional Neurosurgical
Working Group. Only one member from each site was asked to respond to the survey. Responses were collected
from May 15 to June 6, 2020.
Results: Twenty-three sites participated; 19 (83%) sites were from the USA and 4 (17%) from Canada. Twentyone sites were academic medical centers. COVID-19 associated DBS restrictions were in place from 4 to 16 weeks.
One-third of sites halted preoperative evaluations, while two-thirds of the sites offered limited preoperative
evaluations. Institutional policy was the main contributor for the reported practice changes, with 87% of the sites
additionally reporting patient-driven surgical delays secondary to pandemic concerns. Pre-post DBS associated
management changes affected preoperative assessments 96%; electrode placement 87%; new implantable pulse
generator (IPG) placement 83%; IPG replacement 65%; immediate postoperative DBS programming 74%; and
routine DBS programming 91%.
Conclusion: The COVID-19 pandemic related shutdown resulted in DBS practice changes in almost all North
American sites who responded to this large survey. Information learned could inform development of future
contingency plans to reduce patient delays in care under similar circumstances.
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responses were collected from May 15 to June 6, 2020 after the first
shutdown. Survey questions identified practice type and location, and
addressed whether changes occurred in the following areas of DBS
practice: pre-operative assessments, stage 1 electrode placements, stage
2 IPG placement, IPG replacements, post-operative and routine pro
gramming. Where relevant, respondents were asked to provide the best
estimate of their affected volume in respective areas. For example, for
reduction in presurgical evaluation volumes choices included usual
numbers, 1–25% reduction from usual numbers, 26–50%, 51–75%,
76–99% and unable to evaluate. For questions assessing patient counts,
choices included <5, 5–10, 11–15, >15. Otherwise categorical re
sponses were required.

1. Introduction
At the time of writing of this report, the United States has had over 37
million new cases and over 628,000 deaths due to COVID-19. In the
USA, daily cases of COVID-19 initially peaked in April 2020, which was
followed by six subsequent peaks. Canada was less affected than the
USA, with more than 1.4 cases and more than 26,000 deaths [1]. Just
when we thought the vaccines maybe winning the war against COVID,
we are seeing the emergence of more virulent strains with rising cases
especially in the unvaccinated population. Hospitals in some US cities
are again putting elective surgeries on hold due to hospital resources
getting overwhelmed.
During the first shutdown in May 2020, elective surgeries were
canceled in most medical centers in the USA and Canada. DBS related
delays were experienced in DBS patient candidacy screening, preoper
ative surgical preparations and DBS electrode implantation. Under
standing how patient care was managed at centers treating patients with
DBS during the pandemic shutdown will provide essential insights into
contingency planning or long-term practice modifications that might be
integral to sustain access to care for patients with advanced movement
disorders. A previous multicenter report from Italy found that COVID-19
shutdown measures were associated with patient-perceived worsening
of motor and psychiatric symptoms in PD patients with DBS [2],
underscoring the importance of ensuring continued access to care in this
population. Therefore, we surveyed DBS practices in North America on
behalf of the PSG to understand how the pandemic-associated shutdown
impacted DBS associated management. To our knowledge, this is the
only large survey of clinicians on this subject in North America.

3. Results
Twenty-three PSG sites (21 academic, 2 private practice) partici
pated. Nineteen (83%) sites were from the USA and 4 (17%) from
Canada (Appendix A). All sites reported changes in their DBS practice
(Fig. 1). COVID-19-associated restrictions impacted DBS care practices
(preoperative, surgical, and postoperative management) for a median of
8 (range 4–16) weeks.
3.1. Impact on preoperative assessment
All institutions reported cancellation or postponement of preopera
tive assessments driven by institutional policy mandates. 87% of sites
reported that patients also elected to cancel or postpone DBS electrode
implants due to concern for COVID-19 exposure. A third of sites dis
continued preoperative evaluations, while the remaining experienced
reduction in the number of preoperative evaluations. Both neurologists
and neurosurgeons were able to continue patient preoperative evalua
tions at 2/3rd of sites, albeit with markedly reduced numbers. Neuro
psychology evaluations continued at only 1/3rd of sites. 92% of sites
reported that preoperative levodopa motor ON/OFF evaluations were
postponed, although some concurrently conducted it in-person (22%) or
via video-based (13%) assessments. No site made a surgical decision to
proceed with DBS for PD patients without an in-person levodopa motor
ON/OFF evaluation.

2. Methods
This study was approved by the ethics committee of Wake Forest
School of Medicine IRB: IRB00065689. A REDCap® survey was
distributed to all members of the Functional Neurosurgical Working
Group of the PSG. Study data were collected and managed using REDCap
[3] electronic data capture tools hosted at Wake Forest School of Med
icine (UL1TR00142). One member from each site was instructed to
complete the survey based on data from their site activity. Survey

Fig. 1. Percentage of sites reporting affected areas of DBS practice change.
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3.2. Telehealth in preoperative assessment
Preoperative neurological, neurosurgical, and neuropsychological
evaluations were conducted using a combination of in-person, phone,
and video visits. All except one site reported the use of telehealth in such
pre-surgical evaluations. The proportion using video visits was highest,
followed by phone visits and in-person visits. Telehealth use was highest
in neurology, followed by neurosurgery. However, the use of telehealth
by neuropsychology was markedly lower (Fig. 2).

that they could continue as usual (i.e., in-person). 14% of sites offered
programming for the first visit for newly implanted patients. 38% of the
sites offered programming on a case by case basis. 42% of sites deferred
postoperative imaging for documentation of lead location. Routine inperson programming sessions (defined as more than 6 months postimplantation) were performed at half of the sites, but most often when
patients were determined to need urgent evaluation or programming
(73%) and less commonly upon patient request for an in-person session
(27%).

3.3. Impact on surgical practice

3.5. Telehealth Use in DBS programming

All sites reported postponement of electrode placement (Stage 1)
surgery. The majority of sites (55%) estimated the number of Stage 1
surgeries postponed to be between 5 and 10 (range less than 5 to more
than 15), with four sites (18%) having postponed 11 or more stage 1
procedures. Stage 2 implantable pulse generator (IPG) implantation in
any patient was postponed at 83% of the sites and otherwise continued
as scheduled at the remaining sites. Amongst sites reporting IPG related
postponements, 36% estimated postponing less than five cases, 47%
postponed an estimated 5–10 cases, and the remainder postponed
greater than ten. Two sites reported the use of local instead of general
anesthesia for initial IPG implantation to minimize aerosol emission. IPG
replacement surgeries were reported to be postponed by 70% of the
sites, with 44% of sites estimating less than five postponements and 50%
estimating 5–10. Device removal due to infection and hardware mal
function was postponed at one site and two sites respectively. The de
cision to replace an IPG was made on a case-by-case basis by 62% and as
per uniform hospital policy by 38% of the sites. The majority of sites
(86%) did not consider disease type in the decision making process to
replace IPGs, while the remaining did.

Telehealth was used for remote assessment of routine programming
by 68% of the sites. 70% of sites used telehealth only, or estimated using
a predominance of telehealth visits, while 25% reported that more inperson visits than telehealth were utilized for these visits. To accom
plish DBS adjustment remotely, 78% of sites reported using previously
programmed patient control parameters to guide patient self-adjustment
of DBS settings. 65% of sites reported that they enabled patient control
parameters to adjust DBS settings during the shutdown remotely, and
the majority utilized this strategy once enabled. 70% of survey re
spondents rated remote programming capabilities as an essential device
capability to utilize in the future, while 26% said it was ‘somewhat
important.’
4. Discussion
This large North American survey of 23 sites regarding DBS practices
during the initial shutdown from the COVID-19 pandemic confirms
significant effects on all aspects of DBS care, including preoperative,
surgical, and postoperative management. Care delivery by all associated
specialties (neurologists, neurosurgeons, and neuropsychologists) were
impacted during the shutdown with reliance on telemedicine. Although
DBS is considered an elective procedure, unanticipated changes in the
practice or care delivery landscape, or interruption in access to DBSrelated care can prolong or impose substantial disability. During the
initial COVID-19 pandemic shutdown, the challenge was balancing this

3.4. Impact on postoperative care
Postop DBS programming for newly implanted patients was
managed in a variety of ways. 38% of sites reported a complete halt in
programming sessions for this group of patients, while 24% reported

Fig. 2. Telehealth use in pre-op assessments.
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telemedicine. Further work is needed to determine persistence of remote
DBS assessments beyond the pandemic. Telehealth examinations will
need to be validated against standardized in-person exams, especially
for neuropsychological testing. Regulatory and reimbursement policy
changes are needed to permit continued remote assessments. Technol
ogy companies should work with regulatory agencies to hasten the
development of remote programming of DBS devices in a way that is
safe, HIPAA-compliant, and reimbursable.

risk of disability with the risk of exposure to the virus during the act of
seeking care (for patients as well as healthcare workers). Access to cli
nicians was quite often subject to the public health and geographically
heterogeneous institutional policies implemented across the country. As
a consequence of these dynamics, several key findings from this survey
warrant further discussion and exploration.
While preoperative assessments were nearly uniformly canceled or
postponed at sites participating in this survey, an unexpected finding
was that neuropsychological assessment was disproportionately dis
rupted compared to neurology and neurosurgery assessments. While
models of remote DBS assessments exist [4], DBS teams considering a
telehealth contingency plan for remote preoperative assessments should
be aware of unique telehealth challenges to neuropsychology practices
[5].
Recommendations regarding DBS candidacy are dependent on the
assessment of preoperative medication response, which in PD patients
requires the measurement of symptoms both ON and OFF dopaminergic
medications. The importance of this assessment is evidenced by the fact
that none of the sites participating in this survey reported making a
surgical decision in a PD patient without it. Although many sites
implemented remote preoperative neurology evaluations conducted via
video visits [6], its validity in the preoperative assessment of DBS can
didates warrants further investigation.
All sites postponed stage 1 electrode placement surgery in keeping
with the prevailing view that DBS placement is an elective procedure.
While some may challenge this view, especially when considering the
substantial impairment in quality of life experienced by patients pro
ceeding with DBS treatment, the decision to complete stage 2 in cases
where pre-pandemic electrode placement had been performed posed a
different kind of dilemma in terms of how long to delay the procedure.
The proportion of sites postponing IPG replacement was unexpect
edly high at 70%. The potential risks of abrupt cessation of DBS therapy
have been described [7], ranging from symptom recurrence that can be
successfully managed with medication titration to life-threatening dis
ease exacerbations. The postponement of revision related to hardware
malfunction and removal related to infection is also noteworthy in this
context. Although the exact nature and severity of these latter cases were
not explicitly explored in the survey, we believe that such IPG surgeries
should be considered an urgent, non-elective procedure due to the po
tential risks involved [8].
Telehealth methods were used by the majority of sites to conduct
routine post-DBS assessment and management. Since the majority of
DBS devices cannot be comprehensively interrogated or adjusted
remotely, sites developed workarounds to maintain care delivery,
including enabling patient control parameters that clinicians can
instruct patients or caregivers to adjust by telehealth. Limitations
include lack of information about hardware status, difficulties assessing
stimulation-induced side effects, and challenges that patients may have
interacting with their therapy controller [9]. While preliminary evi
dence regarding a remote programming platform exists [10,11], and a
recent clinical trial has investigated the feasibility and safety of remote
programming (ACTRN12619001660178) [12], this technology is device
specific. An overwhelming number of respondents indicated that remote
programming capabilities are considered essential.
Our study had its limitations. The PSG network includes mostly ac
ademic centers, leading to a selection bias in responses received. This
survey assessed the impact of the pandemic-related shutdown on DBS
management without investigating the implementation of various stra
tegies or the impact(s) of these strategies on patient outcomes. Though
this survey was taken immediately after the first shutdown there maybe
less accuracy in reporting numbers.
In conclusion, the COVID-19 pandemic related shutdown resulted in
significant changes in all aspects of DBS care at all sites in North America
who responded to this survey. Sites should have a viable contingency
plan for DBS care if a similar shutdown were to happen again. Many
outpatient DBS-related assessments could be conducted via
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Appendix A. List of Cities of Participating Sites
City

State/Province

Country

Type of DBS Practice

Winston-Salem
Houston
West Bloomfield
Boston
Aurora
Ottawa
Omaha
Montreal
Rochester
NYC
Buffalo
Nashville
Toronto
Boston
Detroit
Toronto
Chicago
Las Vegas
Hershey
Baltimore
Indianapolis
New York
Milwaukee

NC
TX
MI
MA
CO
ON
NE
QC
NY
NY
NY
TN
ON
MA
MI
ON
IL
NV
PA
MD
IN
NY
WI

USA
USA
USA
USA
USA
Canada
USA
Canada
USA
USA
USA
USA
Canada
USA
USA
Canada
USA
USA
USA
USA
USA
USA
USA

Academic
Academic
Private practice
Academic
Academic
Academic
Academic
Academic
Academic
Academic
Academic
Academic
Academic
Private practice
Academic
Academic
Academic
Academic
Academic
Academic
Academic
Academic
Academic
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